Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jean-Pierre Raidot"'
Autor:
Gérard Kandel, J.-P. Cazenave, Isabelle Mendel, Daniel Kientz, Jean-Pierre Raidot, C. Waller, Marie-Louise Wiesel, Hervé Isola, M. Laforet, Laurence Corash
Publikováno v:
Transfusion. 51:622-629
BACKGROUND: The Etablissement Francais du Sang Alsace (EFS Alsace) successively implemented universal use of platelet additive solutions (PASs) and pathogen inactivation (PI) for platelet components (PCs). To assess the impact of these changes, EFS A
Autor:
Jean-Pierre, Cazenave, Hervé, Isola, Chantal, Waller, Isabelle, Mendel, Daniel, Kientz, Michel, Laforêt, Jean-Pierre, Raidot, Gérard, Kandel, Marie-Louise, Wiesel, Laurence, Corash
Publikováno v:
Transfusion. 51(3)
The Etablissement Français du Sang Alsace (EFS Alsace) successively implemented universal use of platelet additive solutions (PASs) and pathogen inactivation (PI) for platelet components (PCs). To assess the impact of these changes, EFS Alsace evalu
Autor:
Gérard Kandel, C. Waller, Daniel Kientz, M. Laforet, Isabelle Mendel, Marie-Louise Wiesel, Jean-Pierre Raidot, Jean-Pierre Cazenave, Hervé Isola
Blood transfusion is a critical supportive therapy for health care. The demand for platelet components (PCs), either derived from apheresis or from whole blood buffy coats, has continually increased as health care technology and life expectancy have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::100de48f912fa7ef373d26cbdb0c7b37
https://doi.org/10.1159/000177239
https://doi.org/10.1159/000177239